SCHEMBL913059

SCHEMBL913059

COc1ccc2[nH]c(=O)oc2c1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.49
ALDH1A1 P00352 3/20 0.49
TERT O14746 4/20 0.47
MAOA P21397 1/20 0.44
CYP19A1 P11511 1/20 0.43
NQO2 P16083 1/20 0.43
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
CA13 Q8N1Q1 2/20 0.41
CA2 P00918 1/20 0.41
MGAM O43451 2/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
NCOA1 Q15788 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31443946 0.81 CREBBP (0.38) KDM4EALDH1A1TERTMAOACA12
SCHEMBL26654849 0.81 CREBBP (0.38) KDM4EALDH1A1TERTMAOACA12
SCHEMBL31457779 0.81 CREBBP (0.38) KDM4EALDH1A1TERTMAOACA12
SCHEMBL12593747 0.81 CREBBP (0.38) TERTMAOACA12CA1CA7
SCHEMBL12593753 0.81 KMO (0.40) KDM4EALDH1A1TERTMAOACYP1A2
SCHEMBL1319411 0.80 AR (0.44) KDM4EALDH1A1TERTMAOACYP19A1
SCHEMBL12903990 0.78 CREBBP (0.38) MAOACREBBPNOS1POLBNOS2
SCHEMBL4413109 0.77 CYP2A6 (0.49) KDM4EALDH1A1MAOANQO2CA12
SCHEMBL4490244 0.70 AR (0.45) MAOACYP19A1CREBBPNOS1POLB
SCHEMBL9054711 0.69 CA12 (0.42) KDM4EALDH1A1CYP19A1NQO2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115035906-B Voice signal blind separation method based on improved butterfly optimization algorithm 大连大学 2024-10-29 CN disclosed
CN-115035906-A Voice signal blind separation method based on improved butterfly optimization algorithm 大连大学 2022-09-09 CN disclosed
US-20110020480-A1 USE OF BENZOXAZINOIDS-CONTAINING CEREAL GRAIN PRODUCTS FOR HEALTH-IMPROVING PURPOSES AARHUS UNIVERSITET (DK) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110020480-A1 USE OF BENZOXAZINOIDS-CONTAINING CEREAL GRAIN PRODUCTS FOR HEALTH-IMPROVING PURPOSES NPY5R, HTR5A, BROX KDM4E 202/4885ALDH1A1 3619/4885TERT 4467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.